Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG.

Othus M., Thomas I., Wang X., Ariti C., Mehta P., Sydenham M., Hills RK., Burnett AK., Nand S., Assouline S., Michaelis LC., Erba HP., Russell N., Kerr KF., Walter RB., Dennis M.

DOI

10.1080/10428194.2022.2131416

Type

Journal article

Journal

Leuk Lymphoma

Publication Date

13/10/2022

Pages

1 - 3

Permalink Original publication